LONDON – May 4th 2021- Bain & Company expands its European Healthcare team with three new hires. Sarwar Islam and Patrick Biecheler join as partners focusing on biopharmaceuticals and private equity in London and Paris respectively; and Giorgio Ortolani joins as a partner in Rome with a focus on pharmaceuticals and medical technology.
Sarwar has 25 years of experience in Biopharma across consulting and as an industry executive. He brings extensive experience in driving growth strategies and large scale transformations for multiple global biopharma and off-patent pharma clients. He has also advised many leading private equity investors on identifying investable assets in healthcare, due diligence and value realization post acquisition. Prior to joining Bain & Company, Sarwar served as a member of the Executive Management team at Concordia International Corp. (Advanz Pharma) and was a partner at another consulting firm. Sarwar also worked as a research scientist at Abbott Laboratories. He was trained as an organic chemist and holds an MBA from the Kellogg School of Management.
Patrick has more than two decades of experience across both consulting and industry roles. He was previously a partner at another global consultancy and worked at AstraZeneca and Sanofi. He is highly regarded in the French healthcare sector for his pharmaceuticals and provider expertise, serving healthcare organizations and private equity funds. Patrick brings extensive expertise within strategy, portfolio management, and operational effectiveness. He also holds an MBA in marketing and finance from ESSEC Business School.
Giorgio has more than 20 years of consulting experience across multiple areas including healthcare services, pharmaceuticals, and medical technology. He has deep expertise in innovative commercial models, growth programs, patient outcomes maximization strategies, life cycle management and digital transformation as well as post-merger integration and cost reduction. Giorgio also has substantial experience in multiple specialty areas and particularly in Oncology and rare diseases – strategic priorities for many pharmaceutical organizations. He holds a Master’s degree in managerial engineering from Tor Vergata University of Rome and a post-graduate MBA from INSEAD.
“Healthcare is core priority for Bain & Company globally and in EMEA, we are delighted to welcome Sarwar, Patrick and Giorgio,” said Loïc Plantevin, Head of Bain & Company’s EMEA Healthcare practice. “The healthcare industry is in the midst of unprecedented change and we are excited to continue to grow our highly talented team across Europe to further work alongside our Corporate and investors clients to address their most important strategic challenges along the entire value chain.”
Editor's Note: To arrange an interview, contact Aliza Medina at firstname.lastname@example.org or +44 207 969 6480
About Bain & Company
Bain & Company is a global consultancy that helps the world’s most ambitious change makers define the future.
Across 61 offices in 38 countries, we work alongside our clients as one team with a shared ambition to achieve extraordinary results, outperform the competition, and redefine industries. We complement our tailored, integrated expertise with a vibrant ecosystem of digital innovators to deliver better, faster, and more enduring outcomes. Our 10-year commitment to invest more than $1 billion in pro bono services brings our talent, expertise, and insight to organizations tackling today’s urgent challenges in education, racial equity, social justice, economic development, and the environment. We earned a gold rating from EcoVadis, the leading platform for environmental, social, and ethical performance ratings for global supply chains, putting us in the top 2% among other consulting firms. Since our founding in 1973, we have measured our success by the success of our clients, and we proudly maintain the highest level of client advocacy in the industry.